Bloomberg Law
April 10, 2019, 9:45 AM UTC

Insulin’s Been Around for a Century, So Why the High Cost?

Jacquie Lee
Jacquie Lee
Reporter

Insulin companies are headed to Capitol Hill April 10 where they’re expected to answer for massive price increases in products that have largely stayed the same for over a decade.

They’ll be joined by the drug middlemen that arrange patients’ coverage options. Those middlemen are also to blame for increased prices, observers say, because the opacity of the whole U.S. drug supply chain allows entities to line their pockets with few consequences.

Insulin prices doubled between 2012 and 2016, according to the Health Care Cost Institute. And although the insulin most commonly used today isn’t the same as the insulin ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.